Robert Hopfner's most recent trade in Rallybio Corp was a trade of 9,196 shares done at an average price of $7.6 . Disclosure was reported to the exchange on Oct. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Dr. Robert Hopfner, M.B.A.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.60 per share. | 12 Oct 2026 | 9,196 | 9,196 | - | 7.6 | 69,890 | - |
| Rallybio Corp | Dr. Robert Hopfner, M.B.A.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 12 Oct 2026 | 3,562 | 12,758 | - | 2.4 | 8,478 | - |
| Rallybio Corp | Dr. Robert Hopfner, M.B.A.,PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.28 per share. | 12 Oct 2026 | 2,062 | 14,820 | - | 15.3 | 31,507 | - |
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.35 per share. | 19 Dec 2025 | 1,000 | 4,026 | - | 17.4 | 17,350 | Common Stock |
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 7,230,283 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 7,145,647 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 3,572,816 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 2,582,243 | 0 | - | - | Series A Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 2,508,575 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 2,104,740 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 1,895,260 | 0 | - | - | Series B Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 1,632,441 | 1,632,441 | - | - | Common Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 1,441,032 | 1,441,032 | - | - | Common Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 313,571 | 0 | - | - | Series C Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 294,502 | 294,502 | - | - | Common Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 25,790 | 0 | - | - | Series Seed Preferred Stock | ||
| Evommune Inc | Dr. Robert Hopfner, M.B.A. | Director, Ten Percent Owner | 07 Nov 2025 | 3,026 | 3,026 | - | - | Common Stock | ||
| Rallybio Corp | Dr. Robert Hopfner, M.B.A. | Director | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | ||
| Rallybio Corp | Dr. Robert Hopfner, M.B.A. | Director | 02 Jan 2025 | 73,571 | 73,571 | - | - | Option (Right to Buy) | ||
| Inozyme Pharma Inc | Robert Hopfner | Director | 18 Jun 2024 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | ||
| Rallybio Corp | Dr. Robert Hopfner, M.B.A.,PhD,R.Ph. | Director | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | ||
| Inozyme Pharma Inc | Robert Hopfner | Director | 01 Aug 2023 | 714,285 | 1,571,741 | - | 4.8 | 3,428,568 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 01 Aug 2023 | 119,048 | 2,923,110 | - | 4.8 | 571,430 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 13 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | ||
| Inozyme Pharma Inc | Robert Hopfner | Director | 11 May 2023 | 228,702 | 3,661,518 | - | 6.3 | 1,429,388 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 11 May 2023 | 219,230 | 3,432,816 | - | 6.5 | 1,420,610 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 29 Mar 2023 | 344,592 | 3,213,586 | - | 4.5 | 1,563,724 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 27 Mar 2023 | 156,766 | 2,868,994 | - | 4.2 | 652,335 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 27 Mar 2023 | 51,074 | 2,712,228 | - | 3.7 | 188,729 | Common Stock | |
| Inozyme Pharma Inc | Robert Hopfner | Director | 10 Jun 2022 | 9,367 | 9,367 | - | - | Stock Option (Right to Buy) | ||
| Rallybio Corp | Dr. Robert Hopfner, PhD | Director | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | ||
| Inozyme Pharma Inc | Robert Hopfner | Director | 19 Apr 2022 | 1,070,000 | 2,661,154 | - | 3.7 | 3,948,300 | Common Stock | |
| Rallybio Corp | Dr. Robert Hopfner, PhD | Director | 03 Jan 2022 | 6,242 | 6,242 | - | - | Option (Right to Buy) |